With the recent approval of multiple gene therapies, including BioMarin's Roctavian for hemophilia A, there's never been a better time to get smart - or smarter - about warranties. Warranties are one of the emerging innovative contracting models that payers and life sciences companies are interested in using to drive access to curative therapies.
read full article ›As we roll into a holiday weekend, a spate of news stories underscores just how important it is to have a nuanced understanding of market access given the complexity of the US health care system.
read full article ›We're hosting a webinar on RE Assist, a tool Real Endpoints has developed to help solve the Medicare copay challenge. RE Assist is compliant, comprehensive, timely, and flexible.
read full article ›There's growing emphasis on the fiduciary responsibility of self-insured employers thanks to the Consolidated Appropriations Act of 2021 (CAA). National Alliance of Healthcare Purchaser Coalitions is out with a call to action for employers to address long-standing conflicts that dog their prescription benefits. Consider the document a playbook for SIEs on what to do in an era where plausible deniability has run its course.
read full article ›Cue payers scrambling to consider how they should cover these meds - and then putting in utilization management based on patients considered highest need. Will be interesting to see what's been learned since the launch of Solvaldi.
read full article ›